Eli Lilly: UK must improve its offering as a ‘small market’ after Brexit Business The UK has become a “relatively small market” since leaving the European Union and must develop a different investment proposition from its counterparts in order to be interesting to multinational corporations, the boss of one of the world’s largest pharmaceuticals firms has said. Speaking shortly after his firm announced it “anticipates making £279m investment over [...]
British Patient Capital invests £90m London biotech company Tech British Patient Capital recently also invested £10m into biotech firm Curve Therapeutics to support its cancer drug discovery technology.